- Home
- NOW vs ABT Comparison
NOW vs ABT Comparison
Compare NOW & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOW
- ABT
- Stock Information
- Founded
- NOW 2004
- ABT 1888
- Country
- NOW United States
- ABT United States
- Employees
- NOW N/A
- ABT N/A
- Industry
- NOW Computer Software: Prepackaged Software
- ABT Medical/Dental Instruments
- Sector
- NOW Technology
- ABT Health Care
- Exchange
- NOW Nasdaq
- ABT Nasdaq
- Market Cap
- NOW 212.3B
- ABT 221.0B
- IPO Year
- NOW 2012
- ABT N/A
- Fundamental
- Price
- NOW $1,011.30
- ABT $133.57
- Analyst Decision
- NOW Strong Buy
- ABT Buy
- Analyst Count
- NOW 31
- ABT 18
- Target Price
- NOW $1,048.97
- ABT $140.44
- AVG Volume (30 Days)
- NOW 1.4M
- ABT 6.6M
- Earning Date
- NOW 07-23-2025
- ABT 07-17-2025
- Dividend Yield
- NOW N/A
- ABT 1.77%
- EPS Growth
- NOW N/A
- ABT 139.92
- EPS
- NOW 7.37
- ABT 7.70
- Revenue
- NOW $11,469,000,000.00
- ABT $42,344,000,000.00
- Revenue This Year
- NOW $19.71
- ABT $7.53
- Revenue Next Year
- NOW $19.40
- ABT $7.69
- P/E Ratio
- NOW $137.17
- ABT $17.34
- Revenue Growth
- NOW 21.01
- ABT 5.00
- 52 Week Low
- NOW $637.99
- ABT $99.71
- 52 Week High
- NOW $1,198.09
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- NOW 59.62
- ABT 54.88
- Support Level
- NOW $994.60
- ABT $131.35
- Resistance Level
- NOW $1,037.67
- ABT $133.84
- Average True Range (ATR)
- NOW 18.37
- ABT 2.33
- MACD
- NOW -6.76
- ABT -0.10
- Stochastic Oscillator
- NOW 32.49
- ABT 67.42
About NOW ServiceNow Inc.
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.